(Funded by the National Institutes of Health)
Researchers from the University of Michigan and the Biointerfaces Institute (Ann Arbor, MI), along with international collaborators, have created nanodiscs that can target cholesterol levels in glioblastoma multiforme, an aggressive form of brain cancer, by starving the cancer cells and increasing survival rates of treated mice. The nanodiscs delivered molecules that increase the number of pumps that can export cholesterol out of tumor cells, resulting in their death. When used in combination with radiation therapy, more than 60% of the mice survived when compared to the mice that only received radiation. The nanodisks also had molecules on their surfaces that activate the body’s immune system. As a result, immune cells not only attacked the tumor but also were able to attack any future tumors.

(Funded by the National Institutes of Health and the U.S. National Science Foundation)
Researchers from the University of Illinois Urbana-Champaign, Purdue University, and the Chan Zuckerberg Biohub Chicago have created DNA origami structures – which are made by folding DNA into nanoscale scaffolds – that can selectively deliver fluorescent imaging agents to pancreatic cancer cells without affecting normal cells. The team experimented with different sizes of tube- and tile-shaped DNA origami structures. They found that tube-shaped structures about 70 nanometers in length and 30 nanometers in diameter, as well as ones that are about 6 nanometers in length and 30 nanometers in diameter, experienced the greatest uptake by the pancreatic cancer tissue while not being absorbed by the surrounding, noncancerous tissue. Larger tube-shaped structures and all sizes of tile-shaped structures did not perform as well.

(Funded by the National Institutes of Health)
A new study by Brown University researchers suggests that gold nanoparticles might one day be used to help restore vision in people with macular degeneration and other retinal disorders. The researchers showed that nanoparticles injected into the retina can successfully stimulate the visual system and restore vision in mice with retinal disorders. The findings suggest that a new type of visual prosthesis system in which nanoparticles, used in combination with a small laser device worn in a pair of glasses or goggles, might one day help people with retinal disorders to see again. The experiments showed that neither the nanoparticle solution nor the laser stimulation caused detectable adverse side effects, as indicated by metabolic markers for inflammation and toxicity.

(Funded by the National Institutes of Health)
Oregon State University researchers have discovered a way to get anti-inflammatory medicine across the blood-brain barrier, opening the door to potential new therapies for a range of conditions, including Alzheimer’s disease, multiple sclerosis, Parkinson’s disease and cancer cachexia. (The blood-brain barrier is a protective shield separating the brain from the bloodstream; it is made up of tightly packed cells lining the blood vessels in the brain and controls what substances can move from the blood to the brain.) The delivery method involves specially engineered nanoparticles. Tested in a mouse model, the nanoparticles reached their intended destination, the hypothalamus, and delivered a drug that inhibits a key protein associated with inflammation.

(Funded by the National Institutes of Health)
Polymer-coated nanoparticles loaded with therapeutic drugs show significant promise for cancer treatment. Over the past decade, researchers at the Massachusetts Institute of Technology (MIT) have created a variety of these nanoparticles using a technique called layer-by-layer assembly. To help move these nanoparticles closer to human use, the researchers have now come up with a manufacturing technique that allows them to generate larger quantities of the nanoparticles in a fraction of the time. The researchers have filed for a patent on the technology and are now working with MIT’s Deshpande Center for Technological Innovation in hopes of potentially forming a company to commercialize the technology.